<?xml version="1.0" ?>
<tei>
	<teiHeader>
		<fileDesc xml:id="55000643"/>
	</teiHeader>
	<text xml:lang="en">
		<front>
<lb/>
	<reference>Journal of Clinical Oncology, 2009 ASCO Annual Meeting Proceedings (Post-Meeting Edition).<lb/> Vol 27, No 15S (May 20 Supplement), 2009: e20013<lb/> </reference>

	<note type="copyright">Â© 2009 American Society of Clinical Oncology<lb/></note>

	<div type="abstract">Abstract<lb/> Possible therapeutic reversal of immune suppression in patients<lb/> with metastatic melanoma by timed delivery of temozolomide<lb/> chemotherapy:A pilot study<lb/></div>

	<byline>
	<docAuthor>F. Quevedo, M. L. Ashdown, V. J. Suman, A. Robinson, L. A. Kottschade, J. S. Kaur,<lb/> E. T. Creagan, R. R. McWilliams and S. N. Markovic<lb/></docAuthor>
	</byline>

	<byline>
	<affiliation>Mayo Clinic, Rochester, MN; ImmunAid, Melbourne, Australia; University of Melbourne,<lb/></affiliation>
	</byline>

	<address>Melbourne, Australia<lb/></address>

	<idno>e20013<lb/> </idno>

	<div type="introduction">Background: Recent evidence suggests that patients with advanced cancer exhibit an</div>

		</front>
	</text>
</tei>
